الفهرس 
Aim of workOnly 14 pages are availabe for public view
 |  | from | 106 |  |  |
| | | from | 106 | | |
Abstract
Infantile haemangiomas (IH) are the most common vascular tumours
among children, occurring in 3% to 10% of infants. Infantile haemangiomas
appear more commonly among Caucasians and being evident in up to 12%
of all children. Infantile haemangiomas affect females in a ratio of 3:1. Sixty
percent of IH are located in the head and neck area, whereas 25% occur on
the trunk and 15% on the extremities.
Management of IH can be challenging. Each option involves
significant drawbacks or side effects, or both. Location, age of the patient,
risk of complications, and growth rate are all factors that physicians must
consider in managing patients with IH.
Surgical management of infantile hemangioma (IH) has an important
role among patients in whom medical treatment is complicated or who have
His in high-risk locations. Although there has been a tendency toward
pharmacologic treatment, it is important to emphasize that there are cases
where the best treatment is still surgery.
The present study reports the outcome of patients in which the primary
surgical indications were functional impairment, bleeding and ulceration,
and cosmetic deformity and the best time of sugical intervention. The study
aimed to assess the best time and type of intervention for infantile
haemangiomas for success of the intervention and prevention of
complication, best cosmetic and psychological outcome.
This study was done at Plastic and Reconstructive Surgery
Department, Menoufia University Hospitals on 30 cases of infantile
haemangioma met treatment criteria were enrolled into the study. We
considered all types of surgical interventions used in the treatment of
Infantile Haemangiomas.
Summary
81
Age ranged between 2 months –15 years with mean value 2.79±4.306
years.
Male cases were 3(10.0%) while female cases were 27(90.0%).
Size of lesion was ranged between 0.5–48 mm2 with mean value
7.80±13.963 mm2
.
Timing of appearance was ranged between 7–60 days with mean value
17.60±15.856 days. Progression was ranged between 3 weeks –18
months with mean value 5.80±5.535 months.
Timing of surgery was ranged between 0.5 –15 years with mean value
4.19±5.130 years.
Type of surgical intervention show that 18(60.0%) the type was
Excision and 1ry closure, 6(20.0%) the type was Bilobed rotational flap,
3(10.0%) the type was Excision and rotational flap and 3(10.0%) the
type was Rotational flap.
Complications included: about 2(6.6%) had recurrence, 2(6.6%) had
wound dehiscence, 3(10.0%) had hypertrophic scar, 3(10.0%) had
alopecia and 1(3.3%) had Inflammation and cellulitis.
Regarding relation between timing of surgery and outcome: in patients
with ≤6 months 3(50.0%) had Hypertrophic scar while in patients with
6months to 3 years 2(11.1%) had recurrence, 2(11.1%) had wound
dehiscence and 3(16.7%) had alopecia and with patients >3years
1(16.7%) had inflammation and cellulitis. There were statistically
significant differences according to Hypertrophic scar.